Helmut Anderten
Hildesheim, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Efficacy and safety of switching basal insulin to insulin glargine 300 U/mL in individuals with inadequately controlled type 2 diabetes on advanced insulin therapies: The Toujeo-Neo T2DM study.
Journal: Diabetes, obesity & metabolism
Published: July 21, 2025
Switching the basal insulin to insulin glargine 300 U/ml in people with type 2 diabetes under basal insulin supported oral therapy: Observational trial on effectiveness and safety.
Journal: Diabetes, obesity & metabolism
Published: June 15, 2021
Preulcerous Risk Situation in Diabetic Foot Syndrome: Proposal for a Simple Ulcer Prevention Score.
Journal: Journal of diabetes science and technology
Published: June 12, 2020
Effectiveness and safety of insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes after failure of oral therapy in a real-world setting.
Journal: Diabetes, obesity & metabolism
Published: June 28, 2019
Titration of insulin glargine 100 U/mL when added to oral antidiabetic drugs in patients with type 2 diabetes: results of the TOP-1 real-world study.
Journal: Acta diabetologica
Published: May 05, 2019
Predictors of treatment response in type-2 diabetes patients initiating basal-supported oral therapy with insulin glargine 100 U/mL: A sub-analysis of the Titration and OPtimisation (TOP) registry.
Journal: Diabetes, obesity & metabolism
Published: March 12, 2019
HbA1c target achievement in the elderly: results of the Titration and Optimization trial for initiation of insulin glargine 100 U/mL in patients with type 2 diabetes poorly controlled on oral antidiabetic drugs.
Journal: BMJ open diabetes research & care
Published: February 18, 2019
Titration and optimization trial for the initiation of insulin glargine 100 U/mL in patients with inadequately controlled type 2 diabetes on oral antidiabetic drugs.
Journal: Diabetes, obesity & metabolism
Published: May 16, 2018
Early discontinuation and related treatment costs after initiation of Basal insulin in type 2 diabetes patients: a German primary care database analysis.
Journal: Journal of diabetes science and technology
Published: January 10, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026